While relatively uncommon, an overdose of calcium channel blockers, beta blockers, or digoxin can result in significant morbidity and mortality, and management can be complex. An acute overdose will require different management strategies than chronic toxicity while on therapeutic dosing. Toxicity from these agents must be considered in bradycardic and hypotensive patients.
Our September supplement, Calcium Channel Blocker and Beta Blocker Overdose, and Digoxin Toxicity Management, presents the current evidence on best practices in the diagnosis and management of CCB, beta blocker, and digoxin toxicity. To help you with the decision-making process, we?ve created the clinical pathway below, which is also included in the supplement.
Last Updated on June 10, 2022